99% Purity Standard Our IGF-1 LR3 consistently meets or exceeds 99% purity as determined by HPLC analysis, ensuring research-grade quality for laboratory applications
Selectivity Advantage: Unlike GHRP-2 and GHRP-6, which non-selectively activate multiple pituitary hormone pathways (ACTH, cortisol, prolactin), ipamorelin demonstrates minimal cross-reactivity with non-target pituitary receptors, making it pharmacologically similar to GHRH in its hormone-releasing selectivity
T., rtoft, G., & Oxlund, H
This stability makes it a highly potent reagent for sustaining cellular signaling in culture media and animal models
In functional medicine, Ipamorelin peptide therapy is often discussed as part of a bigger planlabs, lifestyle, and careful monitoringnot as a quick fix
Researchers often compare CJC-1295 & Ipamorelin Blend with related compounds in the growth hormone pathway research blend category to evaluate similarities in pathway activity, structure, and experimental response